Yishi Yang

Human Positive Coactivator 4 Affects the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma via the mTOR/P70s6k Signaling Pathway

C. Shi, Hai-Su Dai, Xingxing Su, 2020, OncoTargets and therapy.

Studies of the serum HER-2/neu and squamous cell carcinoma-related antigen expression in patients with oral squamous cell carcinoma.

Chi‐Cheng Tsai, Chung-Ho Chen, Yishi Yang, 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Serum CA242: a biomarker for diagnosis, progression, and metastasis in multiple tumors

Hai-Su Dai, Xingxing Su, Yishi Yang, 2020 .

Pumilio RNA-Binding Family Member 1 Plays a Promoting Role on Pancreatic Cancer Angiogenesis

Xingxing Su, Yishi Yang, Yan Jiang, 2022, Canadian Journal of Gastroenterology and Hepatology.

PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells

P. Bie, Zhiyu Chen, Xingxing Su, 2019, Cell Death & Disease.

PUM1 is upregulated by DNA methylation to suppress antitumor immunity and results in poor prognosis in pancreatic cancer

Xingxing Su, Yishi Yang, K. Shen, 2021, Translational cancer research.